0 CHECKOUT

PRODUCT FILTERS

REGION

720
392
389
364
364

COUNTRY

354
48
22
20
19

CATEGORIES

  • 262
  • 252
  • 197
  • 192
  • 183
  • 164
  • 147
  • 145
  • 143
  • 126
  • 117
  • 113
  • 60
  • 58
  • 40

PRICE

158
670
1,167
2,632

PUBLISHED

667
777
1,420
2,632

PRODUCT TYPE

2,512
114
3
2
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

Metastatic Ovarian Cancer-Pipeline Insights

Summary Metastatic Ovarian Cancer- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Metastatic Ovarian Cancer. The main objective of this report to track competitor...

Published:  February 2016
Price:  From

Soft Tissue Sarcoma-Pipeline Insights

Summary Soft Tissue Sarcoma- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Soft Tissue Sarcoma. The main objective of this report to track competitor pipeline...

Published:  February 2016
Price:  From

Neuro Endocrine (Carcinoid) Carcinoma-Pipeline Insights

Summary Neuro Endocrine (Carcinoid) Carcinoma- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Neuro Endocrine (Carcinoid) Carcinoma. The main objective of this...

Published:  February 2016
Price:  From

Neuroendocrine Tumors-Pipeline Insights

Summary Neuroendocrine Tumors- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Neuroendocrine Tumors. The main objective of this report to track competitor pipeline...

Published:  February 2016
Price:  From

Gynecological Cancer-Pipeline Insights

Summary Gynecological Cancer- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Gynecological Cancer. The main objective of this report to track competitor pipeline...

Published:  February 2016
Price:  From

Hairy Cell Leukemia-Pipeline Insights

Summary Hairy Cell Leukemia- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Hairy Cell Leukemia. The main objective of this report to track competitor pipeline...

Published:  February 2016
Price:  From

Malignant Mesothelioma-Pipeline Insights

Summary Malignant Mesothelioma- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Malignant Mesothelioma. The main objective of this report to track competitor pipeline...

Published:  February 2016
Price:  From

Malignant Neoplasms-Pipeline Insights

Summary Malignant Neoplasms- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Malignant Neoplasms. The main objective of this report to track competitor pipeline...

Published:  February 2016
Price:  From

Malignant Pleural Mesothelioma-Pipeline Insights

Summary Malignant Pleural Mesothelioma- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Malignant Pleural Mesothelioma. The main objective of this report to track...

Published:  February 2016
Price:  From

Anaplastic Astrocytoma-Pipeline Insights

Summary Anaplastic Astrocytoma- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Anaplastic Astrocytoma. The main objective of this report to track competitor pipeline...

Published:  February 2016
Price:  From

Biliary Tumor-Pipeline Insights

Summary Biliary Tumor- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Biliary Tumor. The main objective of this report to track competitor pipeline molecules, related...

Published:  February 2016
Price:  From

Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights

Summary Anaplastic Large Cell Lymphoma (ALCL)- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Anaplastic Large Cell Lymphoma (ALCL). The main objective of this...

Published:  February 2016
Price:  From

Anaplastic Thyroid Cancer-Pipeline Insights

Summary Anaplastic Thyroid Cancer- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Anaplastic Thyroid Cancer. The main objective of this report to track competitor...

Published:  February 2016
Price:  From

Bone Cancer-Pipeline Insights

Summary Bone Cancer- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Bone Cancer. The main objective of this report to track competitor pipeline molecules, related...

Published:  February 2016
Price:  From

Endometrial Cancer-Pipeline Insights

Summary Endometrial Cancer- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Endometrial Cancer. The main objective of this report to track competitor pipeline molecules,...

Published:  February 2016
Price:  From

Gastrointestinal Stromal Tumor (GIST)-Pipeline Insights

Summary Gastrointestinal Stromal Tumor (GIST)- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Gastrointestinal Stromal Tumor (GIST). The main objective of this...

Published:  February 2016
Price:  From

Gastrointestinal Tract Cancer-Pipeline Insights

Summary Gastrointestinal Tract Cancer- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Gastrointestinal Tract Cancer. The main objective of this report to track...

Published:  February 2016
Price:  From

Indolent Lymphoma-Pipeline Insights

Summary Indolent Lymphoma- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Indolent Lymphoma. The main objective of this report to track competitor pipeline molecules,...

Published:  February 2016
Price:  From

Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights

Summary Non Muscle Invasive Bladder Cancer (NMIBC)- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Non Muscle Invasive Bladder Cancer (NMIBC). The main objective...

Published:  February 2016
Price:  From

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights

Summary Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Non Muscle Invasive Bladder Cancer...

Published:  February 2016
Price:  From
Loading Indicator

Our Clients